Company intelligence / Profile preview

CyGenica

Balasore/Pune, Odisha/Maharashtra, Indiacygenica.com ↗

Ownership: Private
Development stage: Preclinical

Overview

CyGenica’s lead program—a novel drug conjugate for glioblastoma multiforme—has received Orphan Drug Designation from the US FDA. The company is validating its GEENIE platform for safe, targeted, non-toxic intracellular delivery of a wide range of therapeutic payloads. No published clinical trial results as of June 2025; programs are in preclinical or IND-enabling stages with strong investor and partner interest due to unique technology and regulatory progress.

Therapeutic areas: OncologyRare Diseases
Modalities: Protein-based drug delivery systemsNon-viral intracellular delivery of small molecules, nucleic acids (genes/RNAs/CRISPRs), proteins, and other biomolecules
Industry: Biotech

Drug pipeline

1 asset

CyGenica novel drug conjugate

Preclinical

Partnerships

Strategic partnerships with global biopharmaceutical companies headquartered in Europe or the US to enhance credibility and quality standards. Specific partners not named.

Beyond the preview

Go deeper on CyGenica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CyGenica.

Explore the full profile